The Mechanism Versus PPI Trial for Laryngopharyngeal Reflux

This study is for adults aged 18-89 who have chronic throat symptoms like cough, throat clearing, or hoarseness (dysphonia) and are being evaluated for laryngopharyngeal reflux (LPR). Researchers want to see if a personalized approach, called Laryngeal Recalibration Therapy (LRT) combined with GERD Lifestyle Recommendations and tailored acid suppression, works better than the usual treatment with Omeprazole 40 MG (a proton pump inhibitor, or PPI). The goal is to find out if more people get relief from their symptoms with the personalized approach. You would need to be off acid suppression for at least two weeks before joining.

Study design
This interventional study plans to enroll 160 participants. Researchers will compare a personalized treatment strategy to a usual care strategy.
What's involved
You will undergo screening, including an upper endoscopy and reflux monitoring. After this, you will have an intervention visit about one week later.
Compensation
Not stated in the trial record.
Follow-up
Your symptom response will be measured at 5 years.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06999577

The Mechanism Versus PPI Trial

Recruiting
PHASE4Ages 18–89InterventionalTreatment
University of California, San Diego
~160 participants
Updated 2025-08-01 on ClinicalTrials.gov
What's tested:Omeprazole 40 MGLaryngeal Recalibration TherapyGERD Lifestyle Recommendations

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Symptom Response
Measured over 5 years
Laryngopharyngeal Reflux
Cough
Throat Clearing
Dysphonia
Reflux
1 sites across 1 states
California1
  • Rena Yadlapati, MD · PRINCIPAL_INVESTIGATOR · UC San Diego Health

Opens a ready-to-send draft in your own email app — review before sending.

  • Symptom Response5 years

    Proportion of subjects with symptom response measured by the reflux symptom index (RSI) score.